BLB&B Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-843
| Closed | -$202K | – | 254 |
|
|
2021
Q4 | $202K | Sell |
843
-200
| -19% | -$51.4K | 0.01% | 248 |
|
|
2021
Q3 | $295K | Buy |
1,043
+200
| +24% | +$65.5K | 0.02% | 232 |
|
|
2021
Q2 | $292K | Sell |
843
-1
| -0.1% | -$303 | 0.02% | 216 |
|
|
2021
Q1 | $236K | Sell |
844
-215
| -20% | -$58K | 0.02% | 228 |
|
|
2020
Q4 | $259K | Buy |
1,059
+75
| +8% | +$19.3K | 0.02% | 231 |
|
|
2020
Q3 | $279K | Hold |
984
| – | – | 0.03% | 205 |
|
|
2020
Q2 | $263K | Sell |
984
-44
| -4% | -$13.2K | 0.03% | 209 |
|
|
2020
Q1 | $325K | Hold |
1,028
| – | – | 0.04% | 191 |
|
|
2019
Q4 | $305K | Sell |
1,028
-180
| -15% | -$49.9K | 0.03% | 225 |
|
|
2019
Q3 | $281K | Hold |
1,208
| – | – | 0.03% | 230 |
|
|
2019
Q2 | $283K | Buy |
+1,208
| New | +$279K | 0.03% | 230 |
|
|
2019
Q1 | – | Sell |
-1,195
| Closed | -$360K | – | 279 |
|
|
2018
Q4 | $360K | Sell |
1,195
-178
| -13% | -$56.8K | 0.05% | 202 |
|
|
2018
Q3 | $485K | Buy |
1,373
+58
| +4% | +$20K | 0.06% | 192 |
|
|
2018
Q2 | $382K | Sell |
1,315
-50
| -4% | -$14.1K | 0.05% | 210 |
|
|
2018
Q1 | $374K | Buy |
1,365
+95
| +7% | +$29.5K | 0.05% | 214 |
|
|
2017
Q4 | $405K | Buy |
1,270
+65
| +5% | +$20.9K | 0.06% | 208 |
|
|
2017
Q3 | $377K | Hold |
1,205
| – | – | 0.06% | 206 |
|
|
2017
Q2 | $327K | Hold |
1,205
| – | – | 0.05% | 211 |
|
|
2017
Q1 | $329K | Hold |
1,205
| – | – | 0.06% | 210 |
|
|
2016
Q4 | $342K | Buy |
1,205
+355
| +42% | +$105K | 0.06% | 215 |
|
|
2016
Q3 | $266K | Hold |
850
| – | – | 0.05% | 237 |
|
|
2016
Q2 | $206K | Buy |
+850
| New | +$224K | 0.04% | 254 |
|
Other funds holding BIIB
